ConductScience.org, home

Paper9815919

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

Debinski W and 4 others. Clin Cancer Res, 1995. Cited by 208 papers, by iCite.

Cite this record

ConductScience Library. Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Papers, record 9815919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9815919

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.
PubMed
Journal
Clin Cancer Res
PubMed
Year
1995
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
208
iCite
Relative citation ratio, by iCite
4.64
iCite
Revised in PubMed
2026-01-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Debinski WW
2Obiri NIN I
3Powers SKS K
4Pastan II
5Puri RKR K

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ADP Ribose TransferasesMajor topic
Bacterial ToxinsMajor topic
Brain NeoplasmsMajor topic
ExotoxinsMajor topic
GliomaMajor topic
ImmunotoxinsMajor topic
Interleukin-13Major topic
Neoplasm ProteinsMajor topic
Receptors, InterleukinMajor topic
Virulence FactorsMajor topic
Drug Screening Assays, Antitumor
Humans
Interleukin-13 Receptor alpha1 Subunit
Interleukin-4
Receptors, Interleukin-13
Tumor Cells, Cultured
Pseudomonas aeruginosa Exotoxin A

Source PubMed

Download CSV of topics

Cited by103

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 208 citations.

PMIDTitleJournalYearIn PapersSource
42794993Payload-Free Epitope Imprinted Polymer Nanoparticles Selectively Targeting IL-13Rα2 and Inhibition of Diffuse Midline Glioma Cells.Cancers (Basel)2026https://conductscience.org/library/papers/42794993PubMed
42353280Immunotoxin WPD101a as a Potential Drug Candidate for Targeted Therapy in Muscle Invasive Bladder Cancer Expressing IL-13Rα2-In Vitro Study.Int J Mol Sci2026https://conductscience.org/library/papers/42353280PubMed
42057694Fully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42057694PubMed
41540212Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma.Commun Biol2026https://conductscience.org/library/papers/41540212PubMed
40663259Loss of IL13RA2 promotes metastatic tumor growth in triple-negative breast cancer via increased AKT and NF-κB signaling.Clin Exp Metastasis2025https://conductscience.org/library/papers/40663259PubMed
39204078A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39204078PubMed
38486856Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions.Neurooncol Adv2024https://conductscience.org/library/papers/38486856PubMed
38261143Adjuvant convection-enhanced delivery for the treatment of brain tumors.J Neurooncol2024https://conductscience.org/library/papers/38261143PubMed
38201655Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.Cancers (Basel)2024https://conductscience.org/library/papers/38201655PubMed
37443804Chimeric Antigen Receptor T Cells in Glioblastoma-Current Concepts and Promising Future.Cells2023https://conductscience.org/library/papers/37443804PubMed
37443750Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas.Cells2023https://conductscience.org/library/papers/37443750PubMed
36830725Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.Biomolecules2023https://conductscience.org/library/papers/36830725PubMed
36744399H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics.Expert Opin Ther Targets2023https://conductscience.org/library/papers/36744399PubMed
36303101Clinical and Translational Advances in Glioma Immunotherapy.Neurotherapeutics2022https://conductscience.org/library/papers/36303101PubMed
35832263Convection-Enhanced Arborizing Catheter System Improves Local/Regional Delivery of Infusates Versus a Single-Port Catheter in Ex Vivo Porcine Brain Tissue.J Eng Sci Med Diagn Ther2021https://conductscience.org/library/papers/35832263PubMed
35681612Dialogue among Lymphocytes and Microglia in Glioblastoma Microenvironment.Cancers (Basel)2022https://conductscience.org/library/papers/35681612PubMed
35464460Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.Front Immunol2022https://conductscience.org/library/papers/35464460PubMed
35386310Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy.Bioact Mater2022https://conductscience.org/library/papers/35386310PubMed
34976821Pseudomonas Exotoxin-Based Immunotoxins: Over Three Decades of Efforts on Targeting Cancer Cells With the Toxin.Front Oncol2021https://conductscience.org/library/papers/34976821PubMed
34884607Genetically Modified Cellular Therapies for Malignant Gliomas.Int J Mol Sci2021https://conductscience.org/library/papers/34884607PubMed

See all 103 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL133596PubTator's text mininghttps://conductscience.org/library/genes/3596NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9815919

GET https://conductscience.org/api/papers/v1/9815919/cited_by?page=2